CRM Small/Mid Cap Value Inv

The fund, under normal circumstances, invests at least 80% of its assets in equity and equity related securities of U.S. and non-U.S. companies with market capitalizations at the time of initial purchase within the range of those in the Russell 2500 Value Index or in the S&P Mid Cap 400 Value Index (together, "small/mid cap companies") that are publicly traded on a U.S. securities market.

CRM Small/Mid Cap Value Inv trades as CRMAX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

CRM Small/Mid Cap Value Inv can be compared against peers such as American Beacon Bridgeway Large Cap Value Fund R5 Class, American Beacon Bridgeway Large Cap Value Fund Investor Class, Dean Mid Cap Value, BNY Mellon Opportunistic Small Cap Fund Class I, Hodges Fund a series of Professionally Managed Portfolios, Royce Small-Cap Value Fund - Service Class.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $268.34M, beta of 1.22, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CRMAX currently shows total debt of N/A and beta of 1.22. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-03-31 00:00:00), NPORT-P (2026-03-31 00:00:00), NPORT-P (2026-03-31 00:00:00), NPORT-P (2026-03-31 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.crmfunds.com/funds/crm-small-mid-cap-value/

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.